This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Founded | 1989Denmark | in
---|---|
Type | Fund |
Headquarters | Hellerup, Denmark |
Fields | Life-sciences, natural sciences, social sciences |
Endowment | $167 billion USD (1,114 billion DKK) in 2022[1] |
Website | novonordiskfonden |
The Novo Nordisk Foundation is an international enterprise foundation focusing on medical treatment and research.
In 2023, the foundation had a net worth of $167 billion (1,114 billion DKK),[2][3] making it the wealthiest charitable foundation in the world. Novo Nordisk Foundation owns Novo Holdings A/S, a holding company that is the majority voting shareholder of Novo Nordisk, a Danish pharmaceutical corporation.[4]
From 2016 to 2022, the foundation distributed more than US$4.5 billion in grants for research, innovation, treatment, education, humanitarian and social purposes.[5][6] In 2023, the foundation awarded grants worth 9.1 billion DKK[7] (approx. $1.33 billion)[8] and paid out 5.8 billion DKK[9] (approx. $0.84 billion).
While the main focus lies within biomedicine and biotechnology research, the Foundation also awards grants for research in general practice and family medicine, nursing and art history.